2022年10月28日

嗨,合成生物学行业的投资超过180亿美元在2021年。你可以满足运筹帷幄的使命是谁让生物更容易工程师在明年5月年度活动。如果你整理战略计划和事件明年预算,然后确保包括出席,赞助或展示SynBioBeta 2023。如果你现在远程团队然后让奥克兰万豪本周您的团队的基础和联系Anissa库克作为折扣通过今天。食品科技新闻充满味道:国际风味和香味Inc . (IFF)刚刚宣布开放其新的新加坡创新中心。中心功能超过十创建、设计和分析实验室,项目工作室,烹饪和演示厨房。客户可以见证每一阶段的过程——从构思到商业化——作为一个完整的感官体验。想待在你的健身目标即使你聚会吗?如何在“protein-boosted硬汁”的每一个公司和低俗文化吗?他们的产品增加功能饮料anintriguing新的转折空间:发酵汁含有产生,益生菌,和高度可溶,附近看不见的动物任意鸡蛋蛋白质用微生物,不是鸡。 (Food Navigator) And something that may pair well with animal-free protein juice - New Culture’s first-of-its-kind, animal-free mozzarella in sealed, labeled packaging. As for the main course, Impossible Foods has a big new offering in the works : filet mignon. The first product review makes us want to try it - founder Pat Brown said at MIT Technology Review’s ClimateTech event that his company’s steakprototype is "pretty damn good." (MIT Tech Review) Arzeda has entered into a joint development agreement with AAK to accelerate the innovation of plant-based oils for the food industry through the application of novel enzymes. (Pressrelease) Resources Last week, Meta launched a new VR headset called Meta Quest Pro , and one of its launch partners was the biology company Nanome that has a platform to allow you to design proteins and othermolecules inside a VR collaborative environment. Steve McCloskey spoke at SynBioBeta last year all about this and you'll be able to meet the Nanome team and try it for yourself at SynBioBeta next May. The Network Effects Masterclass: Few understand the hidden complexities of network effects - learn all there is to know about building iconic companies from day one. (NFX) SynBioBeta 2023 speakers: Frank Jaksch, CEO of Ayana Bio, seeks to modernize the health and wellness sector and provide affordable and reliable ingredients. Sri Kosaraju, CEO of Inscripta, is leading the development of a benchtop platform for scalable digital genome engineering. Veronica Wu founded First Bight Ventures as the first venture firm dedicated to early-stage synthetic biology companies that need to scale their operations/technology. Alok Tayi is the Co-Founder and CEO of Vibe Biotechnology, a community of patients, scientists, and partners committed to identifying, funding, and developing promising treatments for rare diseases. Are you joining them at SynBioBeta 2023? You can REGISTER HERE TODAY. Download the application note tolearn how Inscripta’s Onyx® Digital Genome Engineering Platform can be used for rapid strain engineering to improve heterologous protein production. DNA news